about
Benefits and risks of testosterone treatment for hypoactive sexual desire disorder in women: a critical review of studies published in the decades preceding and succeeding the advent of phosphodiesterase type 5 inhibitors.Risks of testosterone replacement therapy in men.Postmenopausal breast cancer, androgens, and aromatase inhibitors.Thrombosis in three postmenopausal women receiving testosterone therapy for low libido.Transdermal Testosterone in Female Hypoactive Sexual Desire Disorder: A Rapid Qualitative Systematic Review Using Grading of Recommendations Assessment, Development and Evaluation.
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Androgens and breast cancer risk.
@en
Androgens and breast cancer risk.
@nl
type
label
Androgens and breast cancer risk.
@en
Androgens and breast cancer risk.
@nl
prefLabel
Androgens and breast cancer risk.
@en
Androgens and breast cancer risk.
@nl
P2860
P1476
Androgens and breast cancer risk.
@en
P2093
Marius J van der Mooren
Peter Kenemans
P2860
P356
10.3109/09513590.2012.651925
P478
28 Suppl 1
P577
2012-03-01T00:00:00Z